732 related articles for article (PubMed ID: 17596691)
41. Increased CSF-BACE 1 activity is associated with ApoE-epsilon 4 genotype in subjects with mild cognitive impairment and Alzheimer's disease.
Ewers M; Zhong Z; Bürger K; Wallin A; Blennow K; Teipel SJ; Shen Y; Hampel H
Brain; 2008 May; 131(Pt 5):1252-8. PubMed ID: 18334538
[TBL] [Abstract][Full Text] [Related]
42. Brain-derived neurotrophic factor, apolipoprotein E genetic variants and cognitive performance in Alzheimer's disease.
Nacmias B; Piccini C; Bagnoli S; Tedde A; Cellini E; Bracco L; Sorbi S
Neurosci Lett; 2004 Sep; 367(3):379-83. PubMed ID: 15337270
[TBL] [Abstract][Full Text] [Related]
43. Effect of ApoE genotype on response to donepezil in patients with Alzheimer's disease.
Choi SH; Kim SY; Na HR; Kim BK; Yang DW; Kwon JC; Park MY
Dement Geriatr Cogn Disord; 2008; 25(5):445-50. PubMed ID: 18401173
[TBL] [Abstract][Full Text] [Related]
44. Object naming and semantic fluency among individuals with genetic risk for Alzheimer's disease.
Miller KJ; Rogers SA; Siddarth P; Small GW
Int J Geriatr Psychiatry; 2005 Feb; 20(2):128-36. PubMed ID: 15660408
[TBL] [Abstract][Full Text] [Related]
45. Presence of an APOE4 allele results in significantly earlier onset of Parkinson's disease and a higher risk with dementia.
Pankratz N; Byder L; Halter C; Rudolph A; Shults CW; Conneally PM; Foroud T; Nichols WC
Mov Disord; 2006 Jan; 21(1):45-9. PubMed ID: 16116614
[TBL] [Abstract][Full Text] [Related]
46. The influence of APOE status on episodic and semantic memory: data from a population-based study.
Nilsson LG; Adolfsson R; Bäckman L; Cruts M; Nyberg L; Small BJ; Van Broeckoven C
Neuropsychology; 2006 Nov; 20(6):645-57. PubMed ID: 17100509
[TBL] [Abstract][Full Text] [Related]
47. ApoE alleles and tau markers in patients with different levels of cognitive impairment.
Lavados M; Farías G; Rothhammer F; Guillon M; Mujica MC; Maccioni C; Maccioni RB
Arch Med Res; 2005; 36(5):474-9. PubMed ID: 16099324
[TBL] [Abstract][Full Text] [Related]
48. Apolipoprotein E epsilon4 allele and lorazepam effects on memory in high-functioning older adults.
Pomara N; Willoughby L; Wesnes K; Greenblatt DJ; Sidtis JJ
Arch Gen Psychiatry; 2005 Feb; 62(2):209-16. PubMed ID: 15699298
[TBL] [Abstract][Full Text] [Related]
49. Effect of APOE ε4 allele on cortical thicknesses and volumes: the AddNeuroMed study.
Liu Y; Paajanen T; Westman E; Wahlund LO; Simmons A; Tunnard C; Sobow T; Proitsi P; Powell J; Mecocci P; Tsolaki M; Vellas B; Muehlboeck S; Evans A; Spenger C; Lovestone S; Soininen H;
J Alzheimers Dis; 2010; 21(3):947-66. PubMed ID: 20693633
[TBL] [Abstract][Full Text] [Related]
50. The association between delirium and the apolipoprotein E epsilon4 allele in the elderly.
van Munster BC; Korevaar JC; de Rooij SE; Levi M; Zwinderman AH
Psychiatr Genet; 2007 Oct; 17(5):261-6. PubMed ID: 17728664
[TBL] [Abstract][Full Text] [Related]
51. [Patterns of cognitive impairment and apolipoprotein genotype in persons with Alzheimer's disease].
Łuczywek E; Pffefer A; Nowicka A; Czyzewski K; ŁaŁowski M; Styczyńska M; Barcikowska M
Neurol Neurochir Pol; 2001; 35(6):1021-33. PubMed ID: 11987699
[TBL] [Abstract][Full Text] [Related]
52. Apolipoprotein E epsilon4 genotype as a risk factor for cognitive decline and dementia: data from the Canadian Study of Health and Aging.
Hsiung GY; Sadovnick AD; Feldman H
CMAJ; 2004 Oct; 171(8):863-7. PubMed ID: 15477624
[TBL] [Abstract][Full Text] [Related]
53. Apolipoprotein E epsilon4 and age at onset of sporadic and familial Alzheimer disease in Caribbean Hispanics.
Olarte L; Schupf N; Lee JH; Tang MX; Santana V; Williamson J; Maramreddy P; Tycko B; Mayeux R
Arch Neurol; 2006 Nov; 63(11):1586-90. PubMed ID: 17101827
[TBL] [Abstract][Full Text] [Related]
54. Genotype (cystatin C) and EEG phenotype in Alzheimer disease and mild cognitive impairment: a multicentric study.
Babiloni C; Benussi L; Binetti G; Bosco P; Busonero G; Cesaretti S; Dal Forno G; Del Percio C; Ferri R; Frisoni G; Ghidoni R; Rodriguez G; Squitti R; Rossini PM
Neuroimage; 2006 Feb; 29(3):948-64. PubMed ID: 16213753
[TBL] [Abstract][Full Text] [Related]
55. Plasma levels of apolipoprotein E and cognitive function in old age.
Mooijaart SP; van Vliet P; van Heemst D; Rensen PC; Berbée JF; Jolles J; de Craen AJ; Westendorp RG
Ann N Y Acad Sci; 2007 Apr; 1100():148-61. PubMed ID: 17460173
[TBL] [Abstract][Full Text] [Related]
56. The apolipoprotein E epsilon4 allele is not associated with cognitive dysfunction in cardiac surgery.
Silbert BS; Evered LA; Scott DA; Cowie TF
Ann Thorac Surg; 2008 Sep; 86(3):841-7. PubMed ID: 18721571
[TBL] [Abstract][Full Text] [Related]
57. Interaction between Apolipoprotein epsilon 4 and traumatic brain injury in patients with Alzheimer's disease and Mild Cognitive Impairment.
Mauri M; Sinforiani E; Bono G; Cittadella R; Quattrone A; Boller F; Nappi G
Funct Neurol; 2006; 21(4):223-8. PubMed ID: 17367583
[TBL] [Abstract][Full Text] [Related]
58. ApoE genotype and cognition after subarachnoid haemorrhage: a longitudinal study.
Louko AM; Vilkki J; Niskakangas T
Acta Neurol Scand; 2006 Nov; 114(5):315-9. PubMed ID: 17022778
[TBL] [Abstract][Full Text] [Related]
59. Apolipoprotein E polymorphism and brain morphology in mild cognitive impairment.
Thomann PA; Roth AS; Dos Santos V; Toro P; Essig M; Schröder J
Dement Geriatr Cogn Disord; 2008; 26(4):300-5. PubMed ID: 18843182
[TBL] [Abstract][Full Text] [Related]
60. APOE ε4 is associated with exacerbation of cognitive decline in patients with multiple sclerosis.
Shi J; Tu JL; Gale SD; Baxter L; Vollmer TL; Campagnolo DI; Tyry TM; Zhuang Y; Kuniyoshi SM
Cogn Behav Neurol; 2011 Sep; 24(3):128-33. PubMed ID: 21945984
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
